Explore the vast range of titles available.

We present the current status of the MATHUSLA (MAssive Timing Hodoscope for Ultra-Stable neutraL pArticles) long-lived particle (LLP) detector at the HL-LHC, covering the design, fabrication and installation at CERN Point 5. MATHUSLA40 is a 40 m-scale detector with an air-filled decay volume that is instrumented with scintillator tracking detectors, to be located near CMS. Its large size, close proximity to the CMS interaction point and about 100 m of rock shielding from LHC backgrounds allows it to detect LLP production rates and lifetimes that are one to two orders of magnitude beyond the ultimate reach of the LHC main detectors. This provides unique sensitivity to many LLP signals that are highly theoretically motivated, due to their connection to the hierarchy problem, the nature of dark matter, and baryogenesis. Data taking is projected to commence with the start of HL-LHC operations. We summarize the new 40m design for the detector that was recently presented in the MATHUSLA Conceptual Design Report, alongside new realistic background and signal simulations that demonstrate high efficiency for the main target LLP signals in a background-free HL-LHC search. We argue that MATHUSLA's uniquely robust expansion of the HL-LHC physics reach is a crucial ingredient in CERN's mission to search for new physics and characterize the Higgs boson with precision.

We present the Conceptual Design Report (CDR) for the MATHUSLA (MAssive Timing Hodoscope for Ultra-Stable neutraL pArticles) long-lived particle detector at the HL-LHC, covering the design, fabrication and installation at CERN Point 5. MATHUSLA is a 40 m-scale detector with an air-filled decay volume that is instrumented with scintillator tracking detectors, to be located near CMS. Its large size, close proximity to the CMS interaction point and about 100 m of rock shielding from HL-LHC backgrounds allows it to detect LLP production rates and lifetimes that are one to two orders of magnitude beyond the ultimate sensitivity of the HL-LHC main detectors for many highly motivated LLP signals. Data taking is projected to commence with the start of HL-LHC operations. We present a new 40m design for the detector: its individual scintillator bars and wavelength-shifting fibers, their organization into tracking layers, tracking modules, tower modules and the veto detector; define a high-level design for the supporting electronics, DAQ and trigger system, including supplying a hardware trigger signal to CMS to record the LLP production event; outline computing systems, civil engineering and safety considerations; and present preliminary cost estimates and timelines for the project. We also conduct detailed simulation studies of the important cosmic ray and HL-LHC muon backgrounds, implementing full track/vertex reconstruction and background rejection, to ultimately demonstrate high signal efficiency and \\(\\ll 1\\) background event in realistic LLP searches for the main physics targets at MATHUSLA. This sensitivity is robust with respect to detector design or background simulation details. Appendices provide various supplemental information.

We report on recent progress and next steps in the design of the proposed MATHUSLA Long Lived Particle (LLP) detector for the HL-LHC as part of the Snowmass 2021 process. Our understanding of backgrounds has greatly improved, aided by detailed simulation studies, and significant R&D has been performed on designing the scintillator detectors and understanding their performance. The collaboration is on track to complete a Technical Design Report, and there are many opportunities for interested new members to contribute towards the goal of designing and constructing MATHUSLA in time for HL-LHC collisions, which would increase the sensitivity to a large variety of highly motivated LLP signals by orders of magnitude.

We report on recent progress in the design of the proposed MATHUSLA Long Lived Particle (LLP) detector for the HL-LHC, updating the information in the original Letter of Intent (LoI), see CDS:LHCC-I-031, arXiv:1811.00927. A suitable site has been identified at LHC Point 5 that is closer to the CMS Interaction Point (IP) than assumed in the LoI. The decay volume has been increased from 20 m to 25 m in height. Engineering studies have been made in order to locate much of the decay volume below ground, bringing the detector even closer to the IP. With these changes, a 100 m x 100 m detector has the same physics reach for large c\\(\\tau\\) as the 200 m x 200 m detector described in the LoI and other studies. The performance for small c\\(\\tau\\) is improved because of the proximity to the IP. Detector technology has also evolved while retaining the strip-like sensor geometry in Resistive Plate Chambers (RPC) described in the LoI. The present design uses extruded scintillator bars read out using wavelength shifting fibers and silicon photomultipliers (SiPM). Operations will be simpler and more robust with much lower operating voltages and without the use of greenhouse gases. Manufacturing is straightforward and should result in cost savings. Understanding of backgrounds has also significantly advanced, thanks to new simulation studies and measurements taken at the MATHUSLA test stand operating above ATLAS in 2018. We discuss next steps for the MATHUSLA collaboration, and identify areas where new members can make particularly important contributions.

ObjectiveCharacterize association between hydrocortisone receipt and hospital outcomes of infants with persistent pulmonary hypertension of the newborn (PPHN).Study designCohort study of infants ≥34 weeks with PPHN who received inhaled nitric oxide at <7 days of age (2010–2016). We generated propensity scores, and performed inverse probability-weighted regression to estimate hydrocortisone effect on outcomes: death, chronic lung disease (CLD), oxygen at discharge.ResultsOf 2743 infants, 30% received hydrocortisone, which was associated with exposure to mechanical ventilation, sedatives, paralytics, or vasopressors (p < 0.001). There was no difference in death, CLD, or oxygen at discharge. In infants with meconium aspiration syndrome, hydrocortisone was associated with decreased oxygen at discharge (odds ratio 0.56; 95% confidence interval 0.21, 0.91).ConclusionsThere was no association between hydrocortisone receipt and death, CLD, or oxygen at discharge in our cohort. Prospective studies are needed to evaluate the effectiveness of hydrocortisone in infants with PPHN.

The introduction and expression of genes in somatic cells is an innovative therapy for correcting genetic deficiency diseases and augmenting immune function. A potential obstacle to gene therapy is the elimination of such gene–modified cells by an immune response to novel protein products of the introduced genes. We are conducting an immunotherapy trial in which individuals seropositive for human immunodeficiency virus (HIV) receive CD8 + HIV–specific cytotoxic T cells modified by retroviral transduction to express a gene permitting positive and negative selection. However, five of six subjects developed cytotoxic T–lymphocyte responses specific for the novel protein and eliminated the transduced cytotoxic T cells. The rejection of genetically modified cells by these immunocompromised hosts suggests that strategies to render gene–modified cells less susceptible to host immune surveillance will be required for successful gene therapy of immunocompetent hosts.